FIELD: organic and radiation chemistry. SUBSTANCE: invention relates to a novel N-[3-(3- cyanopyrazolo[1,5-a]pyrimidine-7-yl)-phenyl-N-ethylacetamide highly labeled with tritium that is an antagonist of benzodiazepine receptors and shows sedative effect. Indicated compound can be used in medicine investigations. EFFECT: new compound indicated above, valuable pharmacological property.
Authors
Dates
2002-06-20—Published
2000-11-15—Filed